Integer Holdings Corporation (NYSE:ITGR) Shares Bought by Townsquare Capital LLC

Key Points

• Townsquare Capital LLC increased its stake in Integer Holdings Corporation by 11.2%, owning 34,992 shares valued at approximately $4.13 million.
• Insider trading activity included significant sales by Directors Martin C. Maxwell and Donald J. Spence, reducing their ownership by 28.23% and 43.97%, respectively.
• Integer reported $1.55 earnings per share for its latest quarter, slightly missing the consensus estimate, but achieved a revenue increase of 11.4% year-over-year.

Townsquare Capital LLC raised its holdings in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 11.2% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 34,992 shares of the medical equipment provider's stock after purchasing an additional 3,525 shares during the period. Townsquare Capital LLC owned about 0.10% of Integer worth $4,129,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ITGR. Opal Wealth Advisors LLC acquired a new position in shares of Integer during the 1st quarter worth $28,000. AdvisorNet Financial Inc purchased a new stake in Integer in the 1st quarter worth approximately $28,000. Bessemer Group Inc. grew its position in Integer by 73.1% during the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock valued at $35,000 after purchasing an additional 125 shares during the last quarter. Sterling Capital Management LLC boosted its position in shares of Integer by 472.9% in the fourth quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after purchasing an additional 279 shares during the period. Finally, Headlands Technologies LLC lifted its holdings in Integer by 1,234.8% during the 1st quarter. Headlands Technologies LLC now owns 1,228 shares of the medical equipment provider's stock valued at $145,000 after buying an additional 1,136 shares in the last quarter. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Stock Down 2.6%

NYSE ITGR traded down $2.82 during trading hours on Thursday, hitting $106.76. 200,151 shares of the company were exchanged, compared to its average volume of 486,909. The firm has a market cap of $3.74 billion, a price-to-earnings ratio of 47.03, a PEG ratio of 0.85 and a beta of 1.02. Integer Holdings Corporation has a 52-week low of $104.93 and a 52-week high of $146.36. The company has a quick ratio of 2.18, a current ratio of 3.41 and a debt-to-equity ratio of 0.72. The company has a 50 day moving average of $115.62 and a two-hundred day moving average of $120.88.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing analysts' consensus estimates of $1.57 by ($0.02). Integer had a net margin of 4.61% and a return on equity of 12.27%. The firm had revenue of $476.00 million during the quarter, compared to analyst estimates of $464.37 million. During the same quarter in the previous year, the business posted $1.30 EPS. Integer's revenue was up 11.4% compared to the same quarter last year. Equities research analysts anticipate that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Benchmark decreased their target price on Integer from $150.00 to $140.00 and set a "buy" rating on the stock in a report on Friday, April 25th. Wall Street Zen upgraded Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. Wells Fargo & Company lowered their price objective on shares of Integer from $152.00 to $132.00 and set an "overweight" rating for the company in a research note on Friday, July 25th. Truist Financial lowered their price target on Integer from $145.00 to $137.00 and set a "buy" rating on the stock in a report on Friday, July 25th. Finally, Citigroup raised Integer from a "hold" rating to a "strong-buy" rating and lifted their price objective for the company from $133.00 to $140.00 in a research report on Thursday, May 22nd. Two analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $140.25.

Insider Buying and Selling at Integer

In other news, Director Donald J. Spence sold 14,739 shares of Integer stock in a transaction on Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the completion of the sale, the director owned 18,781 shares in the company, valued at $2,260,856.78. The trade was a 43.97% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $120.56, for a total value of $1,051,283.20. Following the sale, the director directly owned 22,170 shares of the company's stock, valued at $2,672,815.20. The trade was a 28.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.16% of the stock is currently owned by insiders.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.